Mises à jour réglementaires
Évolutions réglementaires FDA, EMA, TGA et mondiales
Actualités réglementaires
18 mai 2026•3 min de lecture
FDA Releases Updated Guidance on Continuous Manufacturing for Drug Substances
The US FDA has issued new draft guidance clarifying regulatory expectations for continuous manufacturing processes in drug substance production.
Actualités réglementaires
16 mai 2026•3 min de lecture
EMA Updates GMP Requirements for Advanced Therapy Medicinal Products
The European Medicines Agency has published revised GMP guidelines for ATMPs including gene therapies, cell therapies, and tissue-engineered products.
Actualités réglementaires
13 mai 2026•3 min de lecture
ICH Q12 Implementation: Post-Approval Change Management Protocols
A practical overview of how pharmaceutical manufacturers are implementing ICH Q12 lifecycle management principles into their post-approval change management workflows.